Overview

Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma

Status:
Recruiting
Trial end date:
2023-04-30
Target enrollment:
Participant gender:
Summary
Primary objective of the study is to compare the efficacy and safety of CDOP versus CHOP for newly diagnosed peripheral T-cell lymphoma (PTCL).
Phase:
Phase 3
Details
Lead Sponsor:
Peking University
Treatments:
Cyclophosphamide
Doxorubicin
Liposomal doxorubicin
Prednisone
Vincristine